The CAR-T platform of EXCYTE will explore the CAR-T platform with independent intellectual property, including the co-stimulatory molecules such as CD28 and 4-1BB.
The CAR-T platform of EXCYTE will explore the CAR-T platform with independent intellectual property, including the co-stimulatory molecules such as CD28 and 4-1BB.